Literature DB >> 6787097

Use of an improved E. coli method for the measurement of cobalamin in serum: comparison with the E. gracilis assay results.

N A Sourial.   

Abstract

Owing to the higher serum cobalamin results that are obtained by R-binder radioisotopic dilution assay compared to microbiological assays (E. gracilis and L. leichmannii) it was suggested that serum contained a cobamide(s) that could not be detected by the more specific microbiological assays and that a much less specific test organism, which responds to most naturally occurring cobamides, such as the cobamide-dependent E. coli mutant, might respond to these cobamide(s) in serum. In an attempt to investigate this possibility an improved and simplified E. coli assay for the measurement of cobamide in serum was developed. The method is described, and the results obtained in normal subjects, in patients with megaloblastic anemia, and in anaemic pregnant women not suffering from megaloblastic anaemia are reported and compared with E. gracilis assay results.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6787097      PMCID: PMC493289          DOI: 10.1136/jcp.34.4.351

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Vitamin B12 in human blood and serum. I. Comparison of microbiologic assays using normal subjects.

Authors:  H BAKER; O FRANK; I PASHER; H SOBOTKA
Journal:  Clin Chem       Date:  1960-12       Impact factor: 8.327

2.  INVESTIGATIONS INTO THE EUGLENA METHOD FOR THE ASSAY OF THE VITAMIN B12 IN SERUM.

Authors:  B B ANDERSON
Journal:  J Clin Pathol       Date:  1964-01       Impact factor: 3.411

3.  Determination of vitamin B12 with a mutant strain of Escherichia coli.

Authors:  P R BURKHOLDER
Journal:  Science       Date:  1951-11-02       Impact factor: 47.728

4.  Mutants of Escherichia coli requiring methionine or vitamin B12.

Authors:  B D DAVIS; E S MINGIOLI
Journal:  J Bacteriol       Date:  1950-07       Impact factor: 3.490

5.  Improved method for measuring vitamin B12 in serum using intrinsic factor, 57CoB12, and coated charcoal.

Authors:  J L Raven; M B Robson; P L Walker; P Barkhan
Journal:  J Clin Pathol       Date:  1969-03       Impact factor: 3.411

6.  A radiosorbent technique for the assay of serum vitamin B12.

Authors:  L Wide; A Killander
Journal:  Scand J Clin Lab Invest       Date:  1971-04       Impact factor: 1.713

7.  The use of chicken serum for measurement of serum vitamin B12 concentration by radioisotope dilution: discription of method and comparison with microbiological assay results.

Authors:  R Green; P A Newmark; A M Musso; D L Mollin
Journal:  Br J Haematol       Date:  1974-07       Impact factor: 6.998

8.  Comparison of three methods for measuring vitamin B 12 in serum: radioisotopic, euglena gracilis and Lactobacillus leichmannii.

Authors:  J L Raven; M B Robson; J O Morgan; A V Hoffbrand
Journal:  Br J Haematol       Date:  1972-01       Impact factor: 6.998

9.  Megaloblastic anemia of pregnancy in New York City.

Authors:  C Lawrence; F A Klipstein
Journal:  Ann Intern Med       Date:  1967-01       Impact factor: 25.391

10.  Cobalamin analogues are present in human plasma and can mask cobalamin deficiency because current radioisotope dilution assays are not specific for true cobalamin.

Authors:  J F Kolhouse; H Kondo; N C Allen; E Podell; R H Allen
Journal:  N Engl J Med       Date:  1978-10-12       Impact factor: 91.245

  10 in total
  3 in total

1.  Radioimmunoassay that measures serum vitamin B12.

Authors:  J J O'Sullivan; R J Leeming; S S Lynch; A Pollock
Journal:  J Clin Pathol       Date:  1992-04       Impact factor: 3.411

2.  Clinical application of serum vitamin B12 assay.

Authors:  M Rose
Journal:  J Clin Pathol       Date:  1981-04       Impact factor: 3.411

3.  Assessment of a radioisotopic assay for vitamin B12 using an intrinsic factor preparation with R proteins blocked by vitamin B12 analogues.

Authors:  B Bain; G N Broom; J Woodside; R A Litwinczuk; S N Wickramasinghe
Journal:  J Clin Pathol       Date:  1982-10       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.